Cefradine 250mg capsules

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Cefradine

Available from:

Teva UK Ltd

ATC code:

J01DB09

INN (International Name):

Cefradine

Dosage:

250mg

Pharmaceutical form:

Oral capsule

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 05010201; GTIN: 5017007013112 5017007013136

Patient Information leaflet

PATIENT INFORMATION LEAFLET
CEFRADINE 250MG AND 500MG CAPSULES
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU. • KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. • IF YOU HAVE FURTHER QUESTIONS, PLEASE ASK YOUR DOCTOR OR YOUR
PHARMACIST. • THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT TO
OTHERS. IT MAY HARM THEM EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS. • IF YOU GET ANY OF THE SIDE EFFECTS, TALK TO YOUR DOCTOR OR
PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4. WHAT IS IN THIS LEAFLET
1. What Cefradine is and what it is used for
2. What you need to know before you take Cefradine
3. How to take Cefradine
4. Possible side effects
5. How to store Cefradine
6. Contents of the pack and other information WHAT CEFRADINE IS AND WHAT IT IS USED FOR
Cefradine is an antibiotic and belongs to a
family of medicines called cephalosporins.
Cefradine capsules are used to treat a wide
range of bacterial infections including:
• tonsillitis
• sinusitis
• pharyngitis
• laryngo-tracheo bronchitis
• ear infections (otitis media)
• chest infections (bronchitis or pneumonia)
• skin infections
• bladder, urethra (the tube which carries
urine from the bladder) and kidney
infections
It is also used in the prevention of infections
following surgical procedures associated with
a high risk of infection.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CEFRADINE
DO NOT TAKE CEFRADINE CAPSULES IF YOU:
• are allergic to cefradine or any of the
ingredients contained in this medicine; see
section 6 Contents of the pack and other
information.
• are allergic to penicillin antibiotics
• suffer with rare hereditary problems of
galactose intolerance, the Lapp lactase
deficiency or glucose-galactose
malabsorption
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before
taking cefradine if:
• you suffer from kidney problems, as you
may require a lower dose than normal
• you

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Cefradine 250mg Capsules
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 250mg cefradine anhydrous
For excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Capsule, hard.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cefradine 250mg Capsules are used in the treatment of bacterial
infections of
the respiratory and urinary tracts and of the skin and soft tissues.
These
include the following:
Upper respiratory tract infections - sinusitis, pharyngitis,
tonsillitis, laryngo-
tracheo bronchitis and otitis media.
Lower respiratory tract infections - acute and chronic bronchitis,
lobar and
bronchopneumonia.
Urinary tract infections - cystitis, urethritis and pyelonephritis.
Skin and soft tissue infections - impetigo, abscess, cellulitis,
furunculosis.
Cefradine 250mg Capsules are also used in the prophylaxis of
postoperative
infections
following
surgical
procedures
associated
with
a
high
risk
of
infection and for patients with a reduced host resistance to bacterial
infection.
Cefradine should be administered immediately prior to surgery in order
to
ensure sufficient local tissue concentrations at the time that
contamination is
likely to occur. Treatment should be continued during the post
operative
period.
Laboratory testing should be carried out to determine the causative
agents and
their sensitivity to cefradine. However, therapy may commence prior to
receipt
of the sensitivity test results.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults
Respiratory tract infections and skin and soft tissue infections - the
usual dose is
250mg or 500mg four times daily or 500mg or 1g twice daily depending
on the
severity and site of infection.
Urinary tract infections - the usual dose is 500mg four times daily or
1g twice daily.
This may need to be increased for severe or chronic infections.
Prolonged intensive
therapy is needed for complications such as prostatitis and
epididymitis.
Elderly
As for adults. Patients with impaired renal or